3,398 Shares in Astera Labs, Inc. $ALAB Bought by Odyssean LLC

Odyssean LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 3,398 shares of the company’s stock, valued at approximately $1,641,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Glenmede Trust Co. NA increased its holdings in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after acquiring an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the 2nd quarter valued at about $25,000. Lido Advisors LLC grew its position in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the period. Goldstein Advisors LLC grew its position in shares of Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in Astera Labs during the 2nd quarter worth approximately $43,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Trading Up 1.8%

Shares of ALAB opened at $282.65 on Wednesday. The company’s fifty day simple moving average is $348.88 and its 200 day simple moving average is $247.38. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market cap of $49.04 billion, a price-to-earnings ratio of 139.93 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 419,244 shares of company stock worth $163,135,169 in the last 90 days. 10.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Barclays raised their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Finally, Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.